Study of effect of gabapentin on persistent pain after open inguinal hernia repair
| ISRCTN | ISRCTN88541159 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN88541159 |
| Secondary identifying numbers | N0547083244 |
- Submission date
- 12/09/2003
- Registration date
- 12/09/2003
- Last edited
- 18/10/2016
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Digestive System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Jonathan Valentine
Scientific
Scientific
Pain Management Centre
West Norwich Hospital
Bowthorpe Road
Norwich
NR2 3TU
United Kingdom
| Phone | +44 (0)1603 288450 |
|---|---|
| jon.valentine@pain-expert.org |
Study information
| Study design | Randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Hospital |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use contact details to request a participant information sheet |
| Scientific title | Study of effect of gabapentin on persistent pain after open inguinal hernia repair |
| Study objectives | To establish whether gabapentin at a dose of 900-1800 mg per day is effective at reducing persistent pain after open inguinal hernia repair. |
| Ethics approval(s) | Not provided at time of registration |
| Health condition(s) or problem(s) studied | Inguinal hernia |
| Intervention | Randomised controlled trial: gabapentin at a dose of 900 - 1800 mg per day. |
| Intervention type | Drug |
| Pharmaceutical study type(s) | |
| Phase | Not Applicable |
| Drug / device / biological / vaccine name(s) | Gabapentin |
| Primary outcome measure | Not provided at time of registration |
| Secondary outcome measures | Not provided at time of registration |
| Overall study start date | 31/05/2000 |
| Completion date | 31/05/2003 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 32 |
| Key inclusion criteria | 16 subjects, 16 controls |
| Key exclusion criteria | Not provided at time of registration |
| Date of first enrolment | 31/05/2000 |
| Date of final enrolment | 31/05/2003 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
West Norwich Hospital
Norwich
NR2 3TU
United Kingdom
NR2 3TU
United Kingdom
Sponsor information
Department of Health (UK)
Government
Government
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom
| Website | http://www.doh.gov.uk |
|---|
Funders
Funder type
Government
Norfolk and Norwich University Hospital/Norwich Primary Care Trust (PCT) (UK) - East Norfolk and Waveney Research Consortium
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Editorial Notes
18/10/2016: This trial did not take place.
